2D Nanosheets-A New Class of Therapeutic Formulations against Cancer.
Ravichandran ManisekaranRené García-ContrerasAruna-Devi Rasu ChettiarPaloma Serrano-DíazChristian Andrea Lopez-AyusoMa Concepción Arenas-ArrocenaGenoveva Hernández-PadrónLuz M Lopez-MarinLaura Susana Acosta-TorresPublished in: Pharmaceutics (2021)
Researchers in cancer nanomedicine are exploring a revolutionary multifaceted carrier for treatment and diagnosis, resulting in the proposal of various drug cargos or "magic bullets" in this past decade. Even though different nano-based complexes are registered for clinical trials, very few products enter the final stages each year because of various issues. This prevents the formulations from entering the market and being accessible to patients. In the search for novel materials, the exploitation of 2D nanosheets, including but not limited to the highly acclaimed graphene, has created extensive interest for biomedical applications. A unique set of properties often characterize 2D materials, including semiconductivity, high surface area, and their chemical nature, which allow simple decoration and functionalization procedures, structures with high stability and targeting properties, vectors for controlled and sustained release of drugs, and materials for thermal-based therapies. This review discusses the challenges and opportunities of recently discovered 2D nanosheets for cancer therapeutics, with special attention paid to the most promising design technologies and their potential for clinical translation in the future.
Keyphrases
- papillary thyroid
- clinical trial
- squamous cell
- end stage renal disease
- reduced graphene oxide
- chronic kidney disease
- ejection fraction
- lymph node metastasis
- newly diagnosed
- cancer therapy
- highly efficient
- metal organic framework
- young adults
- squamous cell carcinoma
- working memory
- mouse model
- mass spectrometry
- drug delivery
- risk assessment
- climate change
- open label
- solid state